How Chryscap-backed Eris Lifesciences lifted deal valuations in dermatology

Premium

Eris Lifesciences Ltd, a drugmaker backed by private equity firm Chrys Capital, has likely lifted valuations of dermatology-focused businesses in the country as it struck three acquisitions in the segment in less than a year.  Eris, a branded formulations firm offering products in chronic and sub-chronic segments, has spent Rs 1,265 ......